For example, m6A enzyme METTL3 was confirmed to modify targets―LINC00662 and VEGFA to stabilize them and positively regulate their expression levels, thus promoting angiogenesis in CRC, which was demonstrated by the levels of CD31, CD34 and VEGF (138). Here, METTL3 is linked to colorectal carcinoma.